Bell Investment Advisors, Inc Novavax Inc Transaction History

Bell Investment Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$8.86 - $25.04 $88 - $250	-10 Reduced 26.32%	28 $0
Q3 2022 Nov 09, 2022	BUY	$18.2 - $76.12 $527 - $2,207	29 Added 322.22%	38 $1,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $507 - $1,054	-14 Reduced 60.87%	9 $0
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1,480 - $2,397	11 Added 91.67%	23 $3,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $2,133 - $3,246	12 New	12 $2,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.